Q3 2023 Solid-State Li-ion Battery Patent Monitor Report: Notable patent acquisitions by Blue Solutions and Gelion Technologies

SOPHIA ANTIPOLIS, France – October 30, 2023 │The quarterly report for the Q3 2023 Solid-State Li-ion Batteries patent monitor is now available! This report covers all aspects of Solid-state Li-ion batteries from solid electrolyte materials to their use in electrode, battery cells and packs. This quarter, let us shine a spotlight on two notable transfers[…]

October 2023 GaN newsletter: Qromis Substrate Technology (QST) for power GaN and RF GaN devices

SOPHIA ANTIPOLIS, France – October 27, 2023 │The GaN newsletter for October 2023 is now available! This monthly newsletter allows you to keep up to date on the latest scientific publications, patent applications, and news related to III-Nitride semiconductors (GaN, AlN, InN, and alloys) for optoelectronic and electronic applications (power, RF, LED, laser, photonics, and[…]

Q3 2023 Therapeutic mRNA patent monitor report: focus on mRNA modifications for an improved efficiency

SOPHIA ANTIPOLIS, France – October 25, 2023 │ The quarterly report for the Q3 2023 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Let’s focus on an aspect of mRNA design that that ended up in a Nobel prize! mRNA[…]

The power of connecting patents and clinical trials: leveraging competitive intelligence for pharmaceutical companies

SOPHIA ANTIPOLIS, France – October 10, 2023 │ In the pharmaceutical industry, patents are crucial for companies developing new therapies and conducting clinical trials to assess their effectiveness. Given the time-consuming and expensive process of developing a new drug, patents provide legal protection to the company, guaranteeing a period of exclusivity to sell the medication[…]